Leerink Partnrs Issues Positive Outlook for THC Earnings

Tenet Healthcare Co. (NYSE:THC - Free Report) - Leerink Partnrs raised their Q1 2025 earnings per share (EPS) estimates for Tenet Healthcare in a report issued on Tuesday, October 29th. Leerink Partnrs analyst W. Mayo now expects that the company will post earnings of $3.57 per share for the quarter, up from their previous estimate of $2.56. The consensus estimate for Tenet Healthcare's current full-year earnings is $11.38 per share. Leerink Partnrs also issued estimates for Tenet Healthcare's Q2 2025 earnings at $2.66 EPS and Q4 2025 earnings at $3.66 EPS.

Tenet Healthcare (NYSE:THC - Get Free Report) last announced its earnings results on Tuesday, October 29th. The company reported $2.93 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.33 by $0.60. Tenet Healthcare had a return on equity of 24.05% and a net margin of 14.91%. The company had revenue of $5.12 billion for the quarter, compared to analyst estimates of $5.05 billion. During the same period in the prior year, the company posted $1.44 EPS. Tenet Healthcare's quarterly revenue was up 1.1% on a year-over-year basis.

Other equities research analysts also recently issued research reports about the stock. Cantor Fitzgerald boosted their price objective on shares of Tenet Healthcare from $168.00 to $177.00 and gave the company an "overweight" rating in a research report on Wednesday. Wells Fargo & Company increased their price target on Tenet Healthcare from $175.00 to $195.00 and gave the stock an "overweight" rating in a research report on Tuesday, October 22nd. Truist Financial restated a "buy" rating and set a $190.00 price objective (up from $180.00) on shares of Tenet Healthcare in a research note on Wednesday. UBS Group raised their target price on Tenet Healthcare from $197.00 to $217.00 and gave the company a "buy" rating in a research note on Wednesday. Finally, Barclays increased their price objective on shares of Tenet Healthcare from $156.00 to $171.00 and gave the stock an "overweight" rating in a report on Monday, July 29th. One equities research analyst has rated the stock with a hold rating, fourteen have issued a buy rating and four have issued a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Buy" and a consensus price target of $163.65.

Tenet Healthcare Stock Up 0.7 %

NYSE THC traded up $1.11 on Friday, hitting $156.13. 1,192,736 shares of the stock traded hands, compared to its average volume of 1,209,248. The company has a market capitalization of $14.85 billion, a P/E ratio of 5.00, a price-to-earnings-growth ratio of 0.72 and a beta of 2.14. The stock has a 50-day moving average of $159.38 and a 200 day moving average of $142.08. The company has a current ratio of 1.58, a quick ratio of 1.38 and a debt-to-equity ratio of 2.35. Tenet Healthcare has a twelve month low of $52.08 and a twelve month high of $171.20.

Hedge Funds Weigh In On Tenet Healthcare

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Mirae Asset Global Investments Co. Ltd. raised its holdings in shares of Tenet Healthcare by 0.7% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 12,604 shares of the company's stock valued at $1,325,000 after purchasing an additional 90 shares in the last quarter. Optas LLC raised its holdings in Tenet Healthcare by 3.4% during the third quarter. Optas LLC now owns 2,821 shares of the company's stock valued at $469,000 after buying an additional 93 shares in the last quarter. Signaturefd LLC lifted its position in shares of Tenet Healthcare by 17.6% in the third quarter. Signaturefd LLC now owns 628 shares of the company's stock worth $104,000 after buying an additional 94 shares during the last quarter. EverSource Wealth Advisors LLC increased its holdings in shares of Tenet Healthcare by 20.7% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 560 shares of the company's stock valued at $74,000 after acquiring an additional 96 shares during the last quarter. Finally, First Citizens Bank & Trust Co. raised its stake in shares of Tenet Healthcare by 5.1% in the 3rd quarter. First Citizens Bank & Trust Co. now owns 2,226 shares of the company's stock valued at $370,000 after acquiring an additional 109 shares in the last quarter. Institutional investors own 95.44% of the company's stock.

Insider Activity at Tenet Healthcare

In other Tenet Healthcare news, EVP Lisa Y. Foo sold 4,000 shares of Tenet Healthcare stock in a transaction dated Thursday, October 31st. The stock was sold at an average price of $155.94, for a total transaction of $623,760.00. Following the transaction, the executive vice president now owns 15,566 shares of the company's stock, valued at $2,427,362.04. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other Tenet Healthcare news, EVP Lisa Y. Foo sold 4,000 shares of Tenet Healthcare stock in a transaction on Thursday, October 31st. The shares were sold at an average price of $155.94, for a total transaction of $623,760.00. Following the completion of the sale, the executive vice president now owns 15,566 shares of the company's stock, valued at $2,427,362.04. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Saumya Sutaria sold 86,227 shares of the company's stock in a transaction on Wednesday, August 14th. The stock was sold at an average price of $154.41, for a total transaction of $13,314,311.07. Following the completion of the transaction, the chief executive officer now directly owns 13,773 shares in the company, valued at $2,126,688.93. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 132,203 shares of company stock valued at $20,378,757. Company insiders own 0.93% of the company's stock.

Tenet Healthcare declared that its Board of Directors has approved a stock repurchase plan on Wednesday, July 24th that authorizes the company to buyback $1.50 billion in outstanding shares. This buyback authorization authorizes the company to reacquire up to 10.3% of its stock through open market purchases. Stock buyback plans are usually an indication that the company's leadership believes its stock is undervalued.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.